CTN-0043-S: Substance Abuse Treatment Outcomes in Racial/Ethnic Minority Populations

November 4, 2021 /

Carmen Masson, PhD
Lead Investigator
Associate Adjunct Professor, Psychiatry
University of Calfornia, San Francisco
carmen.masson@ucsf.edu

This study addresses the following questions: (1) What is the proportion and number of racial/ethnic minority participants in each CTN clinical trial, and what is their representation across multiple CTN trials?  (2) Do racial/ethnic minority participants in CTN clinical trials experience different attrition than non-minority participants?  (3)  Do racial/ethnic minority participants in CTN clinical trials experience different outcomes than non-minority participants? 

    Node Involvement

    Lead Node(s):

  • Western States Node

    • All Participating Nodes:

  • Western States Node